Implementation of GLA:D Program in West Virginians With Osteoarthritis of the Knee
Primary Purpose
Osteoarthritis, Knee
Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
GLA:D program (Good Life with osteoArthritis in Denmark)
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring knee arthritis, Good Life with Osteoarthritis in Denmark, neuromuscular exercises
Eligibility Criteria
Inclusion Criteria:
- Between 45 to 90 years of age,
- Osteoarthritis of the knee (KOA) (Kellgren and Lawrence grade 2, 3, or 4) confirmed by an orthopedic surgeon based on plain film radiographs and symptoms, and
- Recommendation by an orthopedic surgeon to pursue conservative management of KOA.
Exclusion Criteria:
- Prior joint replacement surgery in the ipsilateral knee,
- Known history of cognitive impairments or any neurodegenerative disease,
- Any other neurological or musculoskeletal pathologies that have resulted in permanent mobility deficits or functional impairments,
- Medical conditions that would preclude them from participating in exercise programs, and
- Inability to read and comprehend English.
Sites / Locations
- School of Physical Therapy, Marshall UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Good Life with Osteoarthritis (GLA:D) Program
Control intervention group
Arm Description
Participants will attend 2 sessions aimed at providing disease-specific education followed by 12 sessions of neuromuscular exercises, each 1 hour in length, delivered twice a week over 6 weeks.
Participants allocated to the control intervention will receive disease-specific education and training to learn home exercises in a 1-hour group session. They will receive a booster session 4-weeks after the first session.
Outcomes
Primary Outcome Measures
Change in Knee injury and Osteoarthritis Outcome Score (KOOS4) scores from baseline to 12-weeks later
The KOOS4 is a variant of full length KOOS that has all subscales of full length KOOS (pain, symptoms, ADL, and QOL) except sports and recreation activities subscale. There are 9 items in the pain subscale, 7 items in the symptom subscale, 17 items in the ADL subscale, and 4 items in the QOL subscale. The items across these subscales are scored on the scale of 0 to 4 where 0 indicates no problem and 4 indicates an extreme problem. Each subscale has sufficient stability and dimensionality, and therefore the score for each subscale is calculated independently on 0-100 interval with 0 indicating an extreme problem and 100 indicating no problems.
Secondary Outcome Measures
Full Information
NCT ID
NCT04857879
First Posted
April 20, 2021
Last Updated
August 30, 2021
Sponsor
Marshall University
Collaborators
University of Toronto, University of Southern Denmark
1. Study Identification
Unique Protocol Identification Number
NCT04857879
Brief Title
Implementation of GLA:D Program in West Virginians With Osteoarthritis of the Knee
Official Title
A Pilot Randomized Controlled Trial to Assess the Implementation and Outcomes of Good Life With Osteoarthritis (GLA:D) Program in West Virginians Suffering From the Osteoarthritis of the Knee
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
August 6, 2021 (Actual)
Primary Completion Date
June 2022 (Anticipated)
Study Completion Date
July 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Marshall University
Collaborators
University of Toronto, University of Southern Denmark
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will examine feasibility of implementing Good Life with Osteoarthritis in Denmark (GLA:D) program in West Virginians with osteoarthritis of the knee
Detailed Description
Using West Virginia (WV) as an implementation site, this study will examine the feasibility of process implementation and effectiveness of the Good Life with Osteoarthritis in Denmark (GLA:D) program in individuals with osteoarthritis of the knee (KOA). Specifically, the study will examine the feasibility and acceptability of the GLA:D program in individuals with KOA. This study will also assess the magnitude of changes in self-reported knee pain and functional impairments as well as physical performance in individuals who receive GLA:D compared to those who receive control interventions consisting of disease-specific education and exercises for KOA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee
Keywords
knee arthritis, Good Life with Osteoarthritis in Denmark, neuromuscular exercises
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Good Life with Osteoarthritis (GLA:D) Program
Arm Type
Experimental
Arm Description
Participants will attend 2 sessions aimed at providing disease-specific education followed by 12 sessions of neuromuscular exercises, each 1 hour in length, delivered twice a week over 6 weeks.
Arm Title
Control intervention group
Arm Type
Active Comparator
Arm Description
Participants allocated to the control intervention will receive disease-specific education and training to learn home exercises in a 1-hour group session. They will receive a booster session 4-weeks after the first session.
Intervention Type
Other
Intervention Name(s)
GLA:D program (Good Life with osteoArthritis in Denmark)
Other Intervention Name(s)
Control intervention
Intervention Description
GLA:D includes disease-specific education combined with neuromuscular exercises. Control interventions include disease-specific education combined with exercises to optimize movement and strength of the affected knee.
Primary Outcome Measure Information:
Title
Change in Knee injury and Osteoarthritis Outcome Score (KOOS4) scores from baseline to 12-weeks later
Description
The KOOS4 is a variant of full length KOOS that has all subscales of full length KOOS (pain, symptoms, ADL, and QOL) except sports and recreation activities subscale. There are 9 items in the pain subscale, 7 items in the symptom subscale, 17 items in the ADL subscale, and 4 items in the QOL subscale. The items across these subscales are scored on the scale of 0 to 4 where 0 indicates no problem and 4 indicates an extreme problem. Each subscale has sufficient stability and dimensionality, and therefore the score for each subscale is calculated independently on 0-100 interval with 0 indicating an extreme problem and 100 indicating no problems.
Time Frame
12-weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Between 45 to 90 years of age,
Osteoarthritis of the knee (KOA) (Kellgren and Lawrence grade 2, 3, or 4) confirmed by an orthopedic surgeon based on plain film radiographs and symptoms, and
Recommendation by an orthopedic surgeon to pursue conservative management of KOA.
Exclusion Criteria:
Prior joint replacement surgery in the ipsilateral knee,
Known history of cognitive impairments or any neurodegenerative disease,
Any other neurological or musculoskeletal pathologies that have resulted in permanent mobility deficits or functional impairments,
Medical conditions that would preclude them from participating in exercise programs, and
Inability to read and comprehend English.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Saurabh P Mehta
Phone
3046965620
Email
mehtas@marshall.edu
Facility Information:
Facility Name
School of Physical Therapy, Marshall University
City
Huntington
State/Province
West Virginia
ZIP/Postal Code
25705
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Saurabh P Mehta, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Implementation of GLA:D Program in West Virginians With Osteoarthritis of the Knee
We'll reach out to this number within 24 hrs